THURSDAY, April 7, 2022 (HealthDay News) — Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of Clinical Oncology. Andrea N. Riner, M.D., M.P.H., from University of Florida in Gainesville, and colleagues assessed the impact of […]